HCW Biologics Ownership | Who Owns HCW Biologics?
HCW Biologics Ownership Summary
HCW Biologics is owned by 8.29% institutional investors, 8.60% insiders, and 83.11% retail investors. Blackrock is the largest institutional shareholder, holding 0.11% of HCWB shares. Abante Quant Value FI is the top mutual fund, with 0.73% of its assets in HCW Biologics shares.
HCWB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | HCW Biologics | 8.29% | 8.60% | 83.11% |
| Sector | Healthcare Stocks | 244.37% | 12.11% | -156.48% |
| Industry | Biotech Stocks | 379.01% | 11.75% | -290.76% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 42.66K | 0.11% | $27.60K |
| Renaissance | 15.00K | 0.04% | $6.69K |
| Bank of america corp /de/ | 156.00 | 0.00% | $101.00 |
| Golden state wealth management | - | - | - |
| Vanguard personalized indexing management | - | - | - |
| Advisor group | - | - | - |
| Two sigma investments, lp | - | - | - |
| Jane street group | - | - | - |
| Tower research capital llc (trc) | - | - | - |
| Geode capital management | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Renaissance | 15.00K | - | $6.69K |
| Golden state wealth management | - | - | - |
| Blackrock | 42.66K | - | $27.60K |
| Tower research capital llc (trc) | - | - | - |
| Vanguard personalized indexing management | - | - | - |
| Advisor group | - | - | - |
| Bank of america corp /de/ | 156.00 | - | $101.00 |
| Jane street group | - | - | - |
| Two sigma investments, lp | - | - | - |
| Geode capital management | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Renaissance | 15.00K | - | 15.00K |
| Northwestern mutual wealth management | - | - | -2.00 |
| Jpmorgan chase | - | - | -9.00 |
| Advisor group | - | - | -26.00 |
| Bank of america corp /de/ | 156.00 | - | -250.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -2.02M |
| Avantax planning partners | - | - | -279.54K |
| Hrt financial lp | - | - | -266.39K |
| Vanguard group | - | - | -243.16K |
| Hightower advisors | - | - | -180.81K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Renaissance | 15.00K | - | 15.00K | $6.69K |
Sold Out
| Holder | Change |
|---|---|
| Northwestern mutual wealth management | -2.00 |
| Jpmorgan chase | -9.00 |
| Advisor group | -26.00 |
| Wells fargo & company/mn | -1.00K |
| Vanguard fiduciary trust | -1.90K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 14 | - | 449,847 | 2.96% | 8 | 1.91% | 11 | 37.50% | - | -100.00% |
| Dec 31, 2025 | 14 | 40.00% | 436,934 | 253.87% | 20 | 69.79% | 8 | 60.00% | 3 | 200.00% |
| Sep 30, 2025 | 10 | 25.00% | 123,473 | 472.48% | 5 | 372.16% | 5 | -16.67% | 1 | -50.00% |
| Jun 30, 2025 | 8 | -46.67% | 21,568 | -98.13% | 1 | 46.00% | 6 | -14.29% | 2 | - |
| Mar 31, 2025 | 15 | -16.67% | 1,155,570 | -63.07% | - | 0.09% | 7 | 75.00% | 2 | -66.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Abante Quant Value FI | 19.80K | 0.73% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.00K | 0.12% | 1.00 |
| Bridgeway Ultra-Small Company Market | 34.70K | 0.08% | -50.00K |
| Fidelity Extended Market Index | 5.36K | 0.06% | - |
| iShares Micro-Cap ETF | 881.00 | 0.04% | - |
| Spartan Extended Market Index Pool E | 13.60K | 0.03% | 800.00 |
| Spartan Extended Market Index Pool F | 1.95K | 0.03% | - |
| Fidelity Series Total Market Index | 1.49K | 0.02% | - |
| NT Ext Equity Mkt Index Fund - NL | 943.00 | 0.01% | 943.00 |
| Spartan Total Market Index Pool E | 3.59K | 0.01% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Wong Hing C | Chief Executive Officer | Buy | $60.00K |
| Jul 29, 2026 | Flowers Lee | SVP of Business Development | Buy | $20.00K |
| Jul 29, 2026 | GARRETT SCOTT T | - | Buy | $20.00K |
| May 22, 2026 | Wong Hing C | Chief Executive Officer | Buy | $160.00K |
| May 22, 2026 | Wong Hing C | Chief Executive Officer | Buy | $145.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | 3 | - |
| 2026 Q2 | 6 | - |
| 2025 Q2 | 15 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
HCWB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools